CHEMICAL COMPOUNDS

본 발명은 HIV 인테그라제(integrase) 억제제의 프로드러그인 화합물에 관한 것이며, 따라서 이러한 화합물은 HIV 복제를 억제하고, HIV에 의한 감염을 예방 및/또는 치료하고, AIDS 및/또는 ARC를 치료하는 데에 유용하다. Herein described are compounds that are prodrugs of HIV integrase inhibitors and therefore are useful in the delivery of compounds for the inhibition of HIV replicati...

Full description

Saved in:
Bibliographic Details
Main Authors WEATHERHEAD JASON GORDON, AOYAMA YASUNORI, JOHNS BRIAN ALVIN, HAKOGI TOSHIKAZU
Format Patent
LanguageEnglish
Korean
Published 09.12.2016
Subjects
ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:본 발명은 HIV 인테그라제(integrase) 억제제의 프로드러그인 화합물에 관한 것이며, 따라서 이러한 화합물은 HIV 복제를 억제하고, HIV에 의한 감염을 예방 및/또는 치료하고, AIDS 및/또는 ARC를 치료하는 데에 유용하다. Herein described are compounds that are prodrugs of HIV integrase inhibitors and therefore are useful in the delivery of compounds for the inhibition of HIV replication, the prevention and/or treatment of infection by HIV, and in the treatment of AIDS and/or ARC. The present invention features synthetic intermediates and their prepartion.
Bibliography:Application Number: KR20167033294